Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment
2007
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
2015
Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients
2013
Doxorubicin pathways
2010 Standout
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
2010
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Treatment of relapse after allogeneic bone marrow transplantation
1996
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
2009
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
2004
Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation
2011
Antibody therapy of cancer
2012 Standout
Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
2013
Clinical Features and Analysis of Risk Factors for Invasive Candidal Infection after Marrow Transplantation
1991
The relationships between resilience of the adults affected by the covid pandemic in Turkey and Covid-19 fear, meaning in life, life satisfaction, intolerance of uncertainty and hope
2020
The pathobiology of mucositis
2004 Standout
Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential
2005 Standout
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
2000
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Oral health care for the cancer patient
1996
A Comparative Review of Colony-Stimulating Factors
1997
Low-energy He/Ne laser in the prevention of radiation-induced mucositis
1999
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity
1998
Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival
2011
Endoscopic, Biopsy, and Histopathologic Guidelines for the Evaluation of Gastrointestinal Inflammation in Companion Animals
2010 Standout
CD43 expression in diffuse large B-cell lymphoma, not otherwise specified: CD43 is a marker of adverse prognosis
2015
Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion
2004
Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
2009
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial
1991
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Immunophenotypic and Histologic Classification of 50 Cases of Feline Gastrointestinal Lymphoma
2009
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Bone marrow and peripheral blood stem cell transplantation for malignancy.
1998
Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment
2001
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Interventions for preventing oral mucositis for patients with cancer receiving treatment
2011
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
1997
Interventions for treating oral mucositis for patients with cancer receiving treatment
2010
Comparative toxicities of 3 platinum‐containing chemotherapy regimens in relapsed/refractory lymphoma patients
2016
Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins
2009
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal Ligation
2015 StandoutNobel
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
2000 Standout
Oral Sequelae of Head and Neck Radiotherapy
2003 Standout
Exploring the Interrelationship between COVID-19 Phobia, Work–Family Conflict, Family–Work Conflict, and Life Satisfaction among School Administrators for Advancing Sustainable Management
2021 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Igor Aurer being referenced
FC RIIIA and FC RIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma
2007
CD43 Expression Is an Adverse Prognostic Factor in Diffuse Large B-Cell Lymphoma
2009
Gemcitabine in the Treatment of Relapsed and Refractory Hodgkin’s Disease
2005
Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
1993
Comparison of the Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Glasgow Prognostic Score in Diffuse Large B-Cell Lymphoma
2016
Are new conditioning regimens for transplants in acute myelogenous leukemia better?
1991
What is the role of recombinant colony stimulating factors in bone marrow transplantation?
1990
Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
1992
The World Health Organization classification of lymphomas.
2002
Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
2010
Aberrant glycosylation of Igg heavy chain in multiple myeloma.
2007
Prostaglandin E2 for prophylaxis of oral mucositis following BMT.
1993